Detalhe da pesquisa
1.
A phase III randomized, multicentre, double blind, active controlled trial to compare the efficacy and safety of two different anagrelide formulations in patients with essential thrombocythaemia - the TEAM-ET 2·0 trial.
Br J Haematol;
185(4): 691-700, 2019 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30919941
2.
CEBPA copy number variations in normal karyotype acute myeloid leukemia: Possible role of breakpoint-associated microhomology and chromatin status in CEBPA mutagenesis.
Blood Cells Mol Dis;
55(4): 284-92, 2015 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26460249
3.
Cladribine added to daunorubicin-cytarabine induction prolongs survival of FLT3-ITD+ normal karyotype AML patients.
Blood;
127(3): 360-2, 2016 Jan 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26567156
4.
Immune thrombocytopenia in patients with chronic lymphocytic leukemia treated with cladribine-based regiments or chlorambucil--follow-up of PALG-CLL randomized trials.
Eur J Haematol;
91(1): 1-9, 2013 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23521128
5.
A risk of essential thrombocythemia in carriers of constitutional CHEK2 gene mutations.
Haematologica;
97(3): 366-70, 2012 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22058216
6.
The germline mutations of the CHEK2 gene are associated with an increased risk of polycythaemia vera.
Br J Haematol;
173(1): 150-2, 2016 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26084796
7.
The early reduction of leukemic blasts in bone marrow on day 6 of induction treatment is predictive for complete remission rate and survival in adult acute myeloid leukemia; the results of multicenter, prospective Polish Adult Leukemia Group study.
Am J Hematol;
86(5): 437-9, 2011 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21465518
8.
Clinical characteristics of patients with chronic eosinophilic leukaemia (CEL) harbouring FIP1L1-PDGFRA fusion transcript--results of Polish multicentre study.
Hematol Oncol;
28(2): 93-7, 2010 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19728396
9.
Cereblon (CRBN) gene polymorphisms predict clinical response and progression-free survival in relapsed/refractory multiple myeloma patients treated with lenalidomide: a pharmacogenetic study from the IMMEnSE consortium.
Leuk Lymphoma;
61(3): 699-706, 2020 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31746254
10.
CD38 gene polymorphisms contribute to genetic susceptibility to B-cell chronic lymphocytic leukemia: evidence from two case-control studies in Polish Caucasians.
Cancer Epidemiol Biomarkers Prev;
18(3): 945-53, 2009 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19240243
11.
A single weekly dose of imatinib is sufficient to induce and maintain remission of chronic eosinophilic leukaemia in FIP1L1-PDGFRA-expressing patients.
Br J Haematol;
141(2): 200-4, 2008 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18307562
12.
Real-life comparison of severe vascular events and other non-hematological complications in patients with chronic myeloid leukemia undergoing second-line nilotinib or dasatinib treatment.
Leuk Lymphoma;
56(8): 2309-14, 2015.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25563556
13.
Treatment of elderly patients with acute myeloid leukemia adjusted for performance status and presence of comorbidities: a Polish Adult Leukemia Group study.
Leuk Lymphoma;
56(8): 2331-8, 2015.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25393675
14.
Weekly imatinib dosage for chronic eosinophilic leukaemia expressing FIP1L1-PDGFRA fusion transcript: extended follow-up.
Br J Haematol;
145(1): 132-4, 2009 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19120352
15.
Long-term results of the Polish Adult Leukemia Group PALG-CLL2 phase III randomized study comparing cladribine-based combinations in chronic lymphocytic leukemia.
Leuk Lymphoma;
55(3): 606-10, 2014 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23721512
16.
Comparison of cladribine plus cyclophosphamide with fludarabine plus cyclophosphamide as first-line therapy for chronic lymphocytic leukemia: a phase III randomized study by the Polish Adult Leukemia Group (PALG-CLL3 Study).
J Clin Oncol;
28(11): 1863-9, 2010 Apr 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20212251
17.
Cladribine in a weekly versus daily schedule for untreated active hairy cell leukemia: final report from the Polish Adult Leukemia Group (PALG) of a prospective, randomized, multicenter trial.
Blood;
109(9): 3672-5, 2007 May 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17209059
18.
Durable remission after treatment with very low doses of imatinib for FIP1L1-PDGFRα-positive chronic eosinophilic leukaemia.
Cancer Chemother Pharmacol;
67(4): 967-9, 2011 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21327932
19.
Cladribine alone and in combination with cyclophosphamide or cyclophosphamide plus mitoxantrone in the treatment of progressive chronic lymphocytic leukemia: report of a prospective, multicenter, randomized trial of the Polish Adult Leukemia Group (PALG CLL2).
Blood;
108(2): 473-9, 2006 Jul 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16551966